Amgen (NasdaqGS:AMGN) received an FDA warning letter regarding a Vectibix promotional video that omitted key risk and indication details. The FDA letter cites concern that the video downplayed serious...
Source LinkAmgen (NasdaqGS:AMGN) received an FDA warning letter regarding a Vectibix promotional video that omitted key risk and indication details. The FDA letter cites concern that the video downplayed serious...
Source Link
Comments